Published in Proc Natl Acad Sci U S A on August 01, 2000
D Mannose in Recurrent Urinary Tract Infections | NCT01808755
Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J (2000) 5.03
Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun (2001) 4.82
The epidemiology of urinary tract infection. Nat Rev Urol (2010) 3.97
The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol (2006) 3.79
Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol (2008) 2.81
Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev (2008) 2.45
Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect Immun (2002) 2.20
Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. Infect Immun (2005) 2.10
Urinary tract infections in adult general practice patients. Br J Gen Pract (2002) 2.10
Cpx signaling pathway monitors biogenesis and affects assembly and expression of P pili. EMBO J (2001) 2.08
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother (2010) 2.05
Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog (2007) 2.01
Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob Agents Chemother (2003) 1.89
Mast cell interleukin-10 drives localized tolerance in chronic bladder infection. Immunity (2013) 1.80
Uroplakins in urothelial biology, function, and disease. Kidney Int (2009) 1.79
Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection. Infect Immun (2002) 1.73
Impact of the RNA chaperone Hfq on the fitness and virulence potential of uropathogenic Escherichia coli. Infect Immun (2008) 1.65
Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection. Proc Natl Acad Sci U S A (2015) 1.62
Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis. Infect Immun (2001) 1.60
Macrophages rapidly transfer pathogens from lipid raft vacuoles to autophagosomes. Autophagy (2005) 1.58
Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev (2012) 1.55
Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex. PLoS One (2008) 1.54
Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection. J Clin Microbiol (2012) 1.53
Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog (2009) 1.53
Bone morphogenetic protein 4 signaling regulates epithelial renewal in the urinary tract in response to uropathogenic infection. Cell Host Microbe (2009) 1.51
Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One (2009) 1.49
TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe (2007) 1.47
Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment. Nature (2009) 1.45
Mechanisms of pain from urinary tract infection. Int J Urol (2014) 1.43
LeuX tRNA-dependent and -independent mechanisms of Escherichia coli pathogenesis in acute cystitis. Mol Microbiol (2007) 1.37
Covert operations of uropathogenic Escherichia coli within the urinary tract. Traffic (2005) 1.35
Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage. Int J Nephrol (2012) 1.31
The type VI secretion system plays a role in type 1 fimbria expression and pathogenesis of an avian pathogenic Escherichia coli strain. Infect Immun (2010) 1.24
Tumor necrosis factor alpha- and inducible nitric oxide synthase-producing dendritic cells are rapidly recruited to the bladder in urinary tract infection but are dispensable for bacterial clearance. Infect Immun (2006) 1.23
G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity. Cell Microbiol (2008) 1.22
Uropathogenic Escherichia coli P and Type 1 fimbriae act in synergy in a living host to facilitate renal colonization leading to nephron obstruction. PLoS Pathog (2011) 1.21
Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli. PLoS Pathog (2009) 1.21
α-Intercalated cells defend the urinary system from bacterial infection. J Clin Invest (2014) 1.18
Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder. Infect Immun (2008) 1.17
CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells. J Cell Biol (2005) 1.17
Extended-spectrum beta-lactamase production is associated with an increase in cell invasion and expression of fimbrial adhesins in Klebsiella pneumoniae. Antimicrob Agents Chemother (2008) 1.16
Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis. Infect Immun (2006) 1.16
Different inflammatory responses are associated with Ureaplasma parvum-induced UTI and urolith formation. BMC Infect Dis (2009) 1.14
Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women. J Infect Dis (2009) 1.14
The innate immune response during urinary tract infection and pyelonephritis. Pediatr Nephrol (2013) 1.10
Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine. FASEB J (2012) 1.10
Uropathogenic Escherichia coli invades host cells via an HDAC6-modulated microtubule-dependent pathway. J Biol Chem (2008) 1.09
Urinary tract infections in women: etiology and treatment options. Int J Gen Med (2011) 1.08
P pilus assembly motif necessary for activation of the CpxRA pathway by PapE in Escherichia coli. J Bacteriol (2004) 1.02
Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors. J Bacteriol (2012) 1.02
Roles of putative type II secretion and type IV pilus systems in the virulence of uropathogenic Escherichia coli. PLoS One (2009) 1.00
TLR-mediated immune responses in the urinary tract. Curr Opin Microbiol (2008) 1.00
Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrob Agents Chemother (2001) 0.99
Interleukin-8 is essential for normal urothelial cell survival. Am J Physiol Renal Physiol (2009) 0.99
Adaptor function of PapF depends on donor strand exchange in P-pilus biogenesis of Escherichia coli. J Bacteriol (2007) 0.97
Uropathogenic Escherichia coli Suppresses the host inflammatory response via pathogenicity island genes sisA and sisB. Infect Immun (2009) 0.94
Forced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirs. PLoS One (2014) 0.93
Host response to probiotics determined by nutritional status of rotavirus-infected neonatal mice. J Pediatr Gastroenterol Nutr (2012) 0.93
NGAL-Siderocalin in kidney disease. Biochim Biophys Acta (2012) 0.92
Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis. PLoS One (2013) 0.92
The Cpx stress response system potentiates the fitness and virulence of uropathogenic Escherichia coli. Infect Immun (2013) 0.92
Response of extraintestinal pathogenic Escherichia coli to human serum reveals a protective role for Rcs-regulated exopolysaccharide colanic acid. Infect Immun (2013) 0.91
Temperature control of fimbriation circuit switch in uropathogenic Escherichia coli: quantitative analysis via automated model abstraction. PLoS Comput Biol (2010) 0.91
Uropathogenic E. coli adhesin-induced host cell receptor conformational changes: implications in transmembrane signaling transduction. J Mol Biol (2009) 0.90
Preferential use of central metabolism in vivo reveals a nutritional basis for polymicrobial infection. PLoS Pathog (2015) 0.89
O-antigen modulates infection-induced pain states. PLoS One (2012) 0.89
Human decay-accelerating factor and CEACAM receptor-mediated internalization and intracellular lifestyle of Afa/Dr diffusely adhering Escherichia coli in epithelial cells. Infect Immun (2008) 0.87
The nature of immune responses to urinary tract infections. Nat Rev Immunol (2015) 0.86
An endogenous ribonuclease inhibitor regulates the antimicrobial activity of ribonuclease 7 in the human urinary tract. Kidney Int (2013) 0.86
Ribonucleases 6 and 7 have antimicrobial function in the human and murine urinary tract. Kidney Int (2014) 0.86
The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections. Expert Rev Anti Infect Ther (2014) 0.85
Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis. MBio (2016) 0.85
Escherichia coli uropathogenesis in vitro: invasion, cellular escape, and secondary infection analyzed in a human bladder cell infection model. Infect Immun (2012) 0.84
Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection. Curr Opin Infect Dis (2015) 0.84
The genome of a blood fluke associated with human cancer. Nat Genet (2012) 0.83
Ureaplasma parvum infection alters filamin A dynamics in host cells. BMC Infect Dis (2011) 0.83
Neutrophil bactericidal function is defective in patients with recurrent urinary tract infections. Urol Res (2003) 0.83
Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection. PLoS Pathog (2015) 0.82
Complicated urinary tract infection is associated with uroepithelial expression of proinflammatory protein S100A8. Infect Immun (2009) 0.81
Amplifying renal immunity: the role of antimicrobial peptides in pyelonephritis. Nat Rev Nephrol (2015) 0.80
A new paradigm of bacteria-gut interplay brought through the study of Shigella. Proc Jpn Acad Ser B Phys Biol Sci (2010) 0.80
Eukaryotic translation elongation factor 1A induces anoikis by triggering cell detachment. J Biol Chem (2012) 0.80
Intracellular Bacterial Communities: A Potential Etiology for Chronic Lower Urinary Tract Symptoms. Urology (2015) 0.79
Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges. Clin Microbiol Rev (2014) 0.79
Comparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host species. Vet Immunol Immunopathol (2016) 0.79
SNX31: a novel sorting nexin associated with the uroplakin-degrading multivesicular bodies in terminally differentiated urothelial cells. PLoS One (2014) 0.79
Identification of Anti-Persister Activity against Uropathogenic Escherichia coli from a Clinical Drug Library. Antibiotics (Basel) (2015) 0.78
Cellular immunity survey against urinary tract infection using pVAX/fimH cassette with mammalian and wild type codon usage as a DNA vaccine. Clin Exp Vaccine Res (2014) 0.78
Reinforcement of epithelial cell adhesion to basement membrane by a bacterial pathogen as a new infectious stratagem. Virulence (2010) 0.78
Characterization of hemolytic Escherichia coli strains in ferrets: recognition of candidate virulence factor CNF1. J Clin Microbiol (2004) 0.78
Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies. Microbiol Mol Biol Rev (2016) 0.78
Asymptomatic bacteriuria Escherichia coli are live biotherapeutics for UTI. PLoS One (2014) 0.77
Genotyping of ESBL Producing Uropathogenic Escherichia coli in West of Iran. Int J Microbiol (2014) 0.76
Dual ligand/receptor interactions activate urothelial defenses against uropathogenic E. coli. Sci Rep (2015) 0.76
Uropathogenic E. coli Exploit CEA to Promote Colonization of the Urogenital Tract Mucosa. PLoS Pathog (2016) 0.76
Biofilm formation and virulence of uropathogenic Escherichia coli in urine after consumption of cranberry-lingonberry juice. Eur J Clin Microbiol Infect Dis (2011) 0.76
Adhesive Pili in UTI Pathogenesis and Drug Development. Pathogens (2016) 0.76
Phylogenetic grouping and pathotypic comparison of urine and fecal Escherichia coli isolates from children with urinary tract infection. Braz J Microbiol (2014) 0.76
Why Serological Responses during Cystitis are Limited. Pathogens (2016) 0.75
New aspects of RpoE in uropathogenic Proteus mirabilis. Infect Immun (2014) 0.75
Caspases: the executioners of apoptosis. Biochem J (1997) 11.99
Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol Microbiol (1998) 10.07
Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells. Cell (1987) 9.80
Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science (1998) 8.16
Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev (1991) 7.11
E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells. Cell (1996) 5.82
Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am (1997) 5.27
Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J (2000) 5.03
X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli. Science (1999) 4.78
Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci U S A (1996) 4.69
Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science (1997) 4.57
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity (1997) 4.19
FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. Proc Natl Acad Sci U S A (1995) 3.51
Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infect Immun (1992) 2.82
The mammalian urinary bladder: an accommodating organ. Biol Rev Camb Philos Soc (1975) 2.71
Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J Clin Invest (1993) 2.65
Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun (1984) 2.35
In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. Proc Natl Acad Sci U S A (1996) 2.35
Neutrophil recruitment and resistance to urinary tract infection. J Infect Dis (1999) 2.23
Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria. Infect Immun (1991) 2.22
Bacterial virulence in urinary tract infection. Infect Dis Clin North Am (1997) 2.20
Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains. Infect Immun (1998) 1.87
Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin Hematol (1997) 1.78
Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies. Antimicrob Agents Chemother (2000) 1.76
Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. J Clin Invest (1997) 1.76
Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature (1997) 1.72
An electron microscopic study of the interaction between vesical epitherlium and E. Coli. Invest Urol (1979) 1.67
Elevated interleukin-8 levels in the urine of patients with urinary tract infections. Infect Immun (1993) 1.64
Bacteriology and ultrastructure of the bladder in patients with urinary tract infections. J Infect (1985) 1.60
Lesions in two Escherichia coli type 1 pilus genes alter pilus number and length without affecting receptor binding. J Bacteriol (1992) 1.57
Neutrophil activation by nascent FimH subunits of type 1 fimbriae purified from the periplasm of Escherichia coli. J Biol Chem (1993) 1.49
Escherichia coli induces transuroepithelial neutrophil migration by an intercellular adhesion molecule-1-dependent mechanism. Infect Immun (1995) 1.47
The pathogenesis of urinary tract infections associated with Escherichia coli, Staphylococcus saprophyticus and S. epidermidis. J Med Microbiol (1990) 1.43
Endotoxin-induced shedding of viable uroepithelial cells is an antimicrobial defense mechanism. Infect Immun (1988) 1.42
Macrophage inflammatory protein-2 is required for neutrophil passage across the epithelial barrier of the infected urinary tract. J Immunol (1999) 1.36
Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection. J Infect Dis (1999) 1.29
Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli. J Exp Med (1996) 1.26
Uroepithelial cells are part of a mucosal cytokine network. Infect Immun (1994) 1.24
P fimbriae-dependent, lipopolysaccharide-independent activation of epithelial cytokine responses. Mol Microbiol (1999) 1.14
Pleiotropic defects of IL-6-deficient mice including early hematopoiesis, T and B cell function, and acute phase responses. Ann N Y Acad Sci (1995) 1.08
Formation of asymmetric unit membrane during urothelial differentiation. Mol Biol Rep (1996) 0.99
Pathogenesis of urinary tract infection. Role of host defenses. Infect Dis Clin North Am (1997) 0.97
Clinical implications of mast cell-bacteria interaction. J Mol Med (Berl) (1998) 0.94
A comparative study of the desquamation of urothelial cells during gestation and in adults mice following moderate stress or endotoxin treatment. Cell Biol Int (1995) 0.81
Nonfimbrial adhesins of Escherichia coli. Adv Exp Med Biol (1996) 0.80
Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science (1998) 8.16
Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science (1999) 6.49
Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J (2000) 5.03
Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun (2001) 4.82
X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli. Science (1999) 4.78
Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science (1997) 4.57
Structural basis of chaperone function and pilus biogenesis. Science (1999) 3.69
FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. Proc Natl Acad Sci U S A (1995) 3.51
P pili in uropathogenic E. coli are composite fibres with distinct fibrillar adhesive tips. Nature (1992) 3.47
Bacterial adhesins: common themes and variations in architecture and assembly. J Bacteriol (1999) 3.01
Outer-membrane PapC molecular usher discriminately recognizes periplasmic chaperone-pilus subunit complexes. Proc Natl Acad Sci U S A (1993) 2.91
Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli. Infect Immun (1985) 2.82
Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli. Infect Immun (1986) 2.65
The chaperone-assisted membrane release and folding pathway is sensed by two signal transduction systems. EMBO J (1997) 2.52
Bacterial pili: molecular mechanisms of pathogenesis. Curr Opin Microbiol (2000) 2.43
Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis (2000) 2.37
Structural basis of pilus subunit recognition by the PapD chaperone. Science (1993) 2.30
Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. J Immunol (2001) 2.27
Immunoglobulin-like PapD chaperone caps and uncaps interactive surfaces of nascently translocated pilus subunits. Proc Natl Acad Sci U S A (1991) 2.25
PapD, a periplasmic transport protein in P-pilus biogenesis. J Bacteriol (1989) 2.19
Multiple pathways allow protein secretion across the bacterial outer membrane. Curr Opin Cell Biol (2000) 2.12
Interactive surface in the PapD chaperone cleft is conserved in pilus chaperone superfamily and essential in subunit recognition and assembly. EMBO J (1992) 2.12
Cpx signaling pathway monitors biogenesis and affects assembly and expression of P pili. EMBO J (2001) 2.08
The PapC usher forms an oligomeric channel: implications for pilus biogenesis across the outer membrane. Proc Natl Acad Sci U S A (1998) 2.01
PapD-like chaperones provide the missing information for folding of pilin proteins. Proc Natl Acad Sci U S A (2000) 1.98
Molecular basis of two subfamilies of immunoglobulin-like chaperones. EMBO J (1996) 1.88
The chaperone/usher pathway: a major terminal branch of the general secretory pathway. Curr Opin Microbiol (1998) 1.86
FimC is a periplasmic PapD-like chaperone that directs assembly of type 1 pili in bacteria. Proc Natl Acad Sci U S A (1993) 1.86
Structural basis of the interaction of the pyelonephritic E. coli adhesin to its human kidney receptor. Cell (2001) 1.79
Conserved immunoglobulin-like features in a family of periplasmic pilus chaperones in bacteria. EMBO J (1992) 1.79
Ramifications of kinetic partitioning on usher-mediated pilus biogenesis. EMBO J (1998) 1.76
Chaperone-assisted self-assembly of pili independent of cellular energy. J Biol Chem (1994) 1.74
Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women. Cancer (1997) 1.70
Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice. Infect Immun (1987) 1.68
PapD chaperone function in pilus biogenesis depends on oxidant and chaperone-like activities of DsbA. Proc Natl Acad Sci U S A (1994) 1.58
Secretion of virulence determinants by the general secretory pathway in gram-negative pathogens: an evolving story. Microbes Infect (2000) 1.53
Neutrophil activation by nascent FimH subunits of type 1 fimbriae purified from the periplasm of Escherichia coli. J Biol Chem (1993) 1.49
Adhesin presentation in bacteria requires molecular chaperones and ushers. Infect Immun (1992) 1.46
Chaperone-assisted pilus assembly and bacterial attachment. Curr Opin Struct Biol (2000) 1.42
Bacterial exposure induces and activates matrilysin in mucosal epithelial cells. J Cell Biol (2000) 1.41
Assembly of complex organelles: pilus biogenesis in gram-negative bacteria as a model system. Methods (2000) 1.41
Snapshots of usher-mediated protein secretion and ordered pilus assembly. Proc Natl Acad Sci U S A (2000) 1.40
Periplasmic chaperone recognition motif of subunits mediates quaternary interactions in the pilus. EMBO J (1998) 1.40
Management of chyloperitoneum after abdominal aortic surgery. Am J Surg (1993) 1.38
The impact of glaucoma on the quality of life of patients in Norway. I. Results from a self-administered questionnaire. Acta Ophthalmol Scand (2001) 1.32
Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer. Clin Cancer Res (1997) 1.32
Development of pilus organelle subassemblies in vitro depends on chaperone uncapping of a beta zipper. Proc Natl Acad Sci U S A (1996) 1.26
The impact of glaucoma on the quality of life of patients in Norway. II. Patient response correlated to objective data. Acta Ophthalmol Scand (2001) 1.21
Stable fiber-forming and nonfiber-forming chaperone-subunit complexes in pilus biogenesis. J Biol Chem (1994) 1.21
Design and evaluation of pilicides: potential novel antibacterial agents directed against uropathogenic Escherichia coli. Chembiochem (2001) 1.20
Haemophilus influenzae pili are composite structures assembled via the HifB chaperone. Proc Natl Acad Sci U S A (1996) 1.20
Structure and function of Escherichia coli type 1 pili: new insight into the pathogenesis of urinary tract infections. J Infect Dis (2001) 1.17
Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico. Vaccine (2001) 1.16
Pharmacokinetics of single-dose oral and intramuscular ketorolac tromethamine in the young and elderly. J Clin Pharmacol (1990) 1.15
Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J Immunol (1996) 1.14
Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women. J Infect Dis (2009) 1.14
Pilus biogenesis via the chaperone/usher pathway: an integration of structure and function. J Struct Biol (1998) 1.08
A novel secretion apparatus for the assembly of adhesive bacterial pili. Trends Microbiol (1993) 1.07
Molecular dissection of PapD interaction with PapG reveals two chaperone-binding sites. Mol Microbiol (1995) 1.04
Dynamic interactions between host and pathogen during acute urinary tract infections. Urology (2001) 0.99
C-Terminal properties are important for ring-fused 2-pyridones that interfere with the chaperone function in uropathogenic E. coli. Org Biomol Chem (2005) 0.98
Structural basis of chaperone self-capping in P pilus biogenesis. Proc Natl Acad Sci U S A (1999) 0.95
Pathogenic amoebae in natural thermal waters of three resorts of Hidalgo, Mexico. Environ Res (1989) 0.95
Genetic, biochemical, and structural studies of biogenesis of adhesive pili in bacteria. Methods Enzymol (1994) 0.93
The PapG tip adhesin of P fimbriae protects Escherichia coli from neutrophil bactericidal activity. Infect Immun (1994) 0.92
PapD-like chaperones and pilus biogenesis. Semin Cell Dev Biol (2000) 0.92
Structural requirements for the glycolipid receptor of human uropathogenic Escherichia coli. Mol Microbiol (1995) 0.92
Shoelace technique for delayed primary closure of fasciotomies. Am J Surg (1994) 0.91
MR angiography of the foot and ankle. J Magn Reson Imaging (1995) 0.91
Probing conserved surfaces on PapD. Mol Microbiol (1999) 0.90
Cell biology. Bacterial spelunkers. Science (2000) 0.87
Stereoselective synthesis of optically active beta-lactams, potential inhibitors of pilus assembly in pathogenic bacteria. Org Lett (2000) 0.86
Binding of pili from uropathogenic Escherichia coli to membranes secreted by human colonocytes and enterocytes. Infect Immun (1999) 0.83
Pharmacokinetics and pharmacodynamics of long-acting propranolol 60-mg capsules: a comparative evaluation. J Clin Pharmacol (1987) 0.83
Role of intestinal surfactant-like particles as a potential reservoir of uropathogenic Escherichia coli. Biochim Biophys Acta (2000) 0.81
Evidence for donor strand complementation in the biogenesis of Haemophilus influenzae haemagglutinating pili. Mol Microbiol (2000) 0.81
Phosphoprotein phosphatase of human central nervous system myelin: purification to apparent homogeneity of a low Mr phosphatase and characterization of the high Mr phosphatase. FEBS Lett (1980) 0.79
The stepped hybrid plate for carpal panarthrodesis - Part II: a multicentre study of 52 arthrodeses. Vet Comp Orthop Traumatol (2009) 0.78
PapG adhesin from E. coli J96 recognizes the same saccharide epitope when present on whole bacteria and as isolated protein. Bioorg Med Chem (1996) 0.77
Parasite contamination of soil in households of a Mexican rural community endemic for neurocysticercosis. Trans R Soc Trop Med Hyg (2008) 0.76
Bacteria thread the needle. Nature (2001) 0.75
Characteristics of a population undergoing treatment for drug addiction in a therapeutic community setting in Spain. Bull Narc (1988) 0.75
Vitamin E levels in human atherosclerotic plaque: the influence of risk factors. Atherosclerosis (1996) 0.75
Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol (1983) 0.75
[Organizing a medical psychological reception center]. Soins Psychiatr (1997) 0.75
Spoof four-wave mixing for all-optical wavelength conversion. Opt Express (2012) 0.75
A customizable multi-channel stimulator for cortical neuroprosthesis. Conf Proc IEEE Eng Med Biol Soc (2007) 0.75
Transferred nuclear Overhauser effect spectroscopy study of a peptide from the PapG pilus subunit bound by the Escherichia coli PapD chaperone. FEBS Lett (1997) 0.75
Staff development program for identifying and resolving drug therapy problems. Am J Health Syst Pharm (1996) 0.75
[Use of vision aids in the elderly]. Tidsskr Nor Laegeforen (1988) 0.75
Specificity mapping of bacterial lectins by inhibition of hemagglutination using deoxy and deoxyfluoro analogs of receptor-active saccharides. Methods Enzymol (1995) 0.75
Electrophysiologic testing of tocainide and mexiletine for ventricular tachycardia: assessment of the need to test both drugs. Am Heart J (1986) 0.75
Binding of peptides in solution by the Escherichia coli chaperone PapD as revealed using an inhibition ELISA and NMR spectroscopy. Bioorg Med Chem (1998) 0.75